Valuation vs Own History COMMODITY
— slow-moving; 60d lag; EV/EBITDA canonical
Research notes (read before interpreting):- The news-vs-expectations thesis is UNTESTED by the backtest (look-ahead-impossible). Only Agent 6 live forward-tracking can validate whether news_adj improves outcomes. Treat news as a bounded refinement on trial, not a proven driver.
- Fundamentals are annual with a 60-day reporting lag; EV/EBITDA is the valuation metric (P/E broke on 45 loss-year rows). Valuation reads are slow-moving, not point-in-time precise.
Percentile within this ticker's own 4-year fundamental history. High = expensive vs itself.
| FY | EV/EBITDA | P/E | P/S | Revenue | EPS |
|---|
| 2025 |
23.11x |
neg |
6.07x |
$5.1B |
$-2.75 |
| 2024 |
52.99x |
neg |
8.45x |
$1.9B |
$-2.33 |
| 2023 |
-42.05x |
neg |
70.54x |
$229M |
$-1.47 |
| 2022 |
0.00x |
neg |
1020.16x |
$16M |
$-0.08 |
Earnings Surprise Track Record COMMODITY
Canonical signal: avoid-misses is the durable edge (misses lag the basket ~4%/21d excess); beats merely match the sector once drift is stripped. Regime-dependent, effectively small-sample — not proven.
| Date | EPS act | EPS est | EPS surp% |
Rev surp% | Excess/21d |
| 2026-05-07 |
$-1.11 |
$-0.92 |
-20.7% |
+5.5% |
n/a |
| 2026-02-26 |
$-0.89 |
$-0.50 |
-78.1% |
+1.5% |
-3.6% |
| 2025-11-10 |
$-0.08 |
$-0.40 |
+79.7% |
+6.1% |
-3.7% |
| 2025-08-12 |
$-0.27 |
$-0.23 |
-16.4% |
+12.1% |
-11.0% |
| 2025-05-15 |
$-0.78 |
— |
— |
— |
+103.1% |
Consensus EPS Revision Trajectory COMMODITY
Forward-year consensus EPS over time — shows how estimates move after each print. Data accrues forward from snapshot start date.
News Lean UNPROVEN LIVE
— UNPROVEN LIVE-ONLY: no historical validation possible
▲ bullish
long
2026-08-12
Q3 guidance well above Street's range; backlog growth plus Piper Sandler top-AI-infra-pick rating reinforce structural demand exceeds near-term delivery capacity.
source ↗
▲ bullish
long
2026-08-07
Multiple catalysts stack on top of existing Leidos defense deal and +20% weekly move; APAC expansion + SSD supply security address the key investor concerns (geographic concentration, supply bottlenecks); but avg PT $141 vs Rosenblatt $250 shows wide dispersion ahead of Aug 11 earnings
source ↗
▲ bullish
long
2026-08-06
New capacity plans signal demand absorption of $99B backlog is accelerating — ahead of Aug 11 earnings this de-risks execution concerns and implies revenue visibility above the $2.56B consensus; Rosenblatt $250 PT vs current ~$80 range signals expectation mismatch.
source ↗
▲ bullish
near
2026-08-05
Stock +28% in 2 days pricing in Q2 beat before Aug 11 print; 167% YoY revenue growth baked into elevated valuation; high debt ($29.8B) and negative net income means any capex narrative shift would be severe.
source ↗
▲ bullish
near
2026-08-04
Big tech cloud beats act as a leading indicator for CRWV capacity absorption; demand-supply ratio 4:1 exceeds what the revenue guide implies—Aug 11 print likely at/above guidance midpoint
source ↗
Analyst Context — the consensus we're trying to beat
Consensus PT
$139.42
+59.2% from current
Price targets from FMP consensus. Not a recommendation.
Stock Demon
Overview
Strategy
Portfolio
Earnings
Digest
Health
Architecture
Private cockpit · Not investment advice